moxifloxacin has been researched along with Brugada Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cools, F; Danhof, M; Gallacher, DJ; Gotta, V; Morissette, P; Sannajust, F; van Ammel, K; van der Graaf, PH; Visser, SA | 1 |
Extramiana, F; Leenhardt, A; Maison-Blanche, P | 1 |
1 review(s) available for moxifloxacin and Brugada Syndrome
Article | Year |
---|---|
Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Moxifloxacin; Phenethylamines; Potassium Channel Blockers; Reproducibility of Results; Sotalol; Sulfonamides; Telemetry; Translational Research, Biomedical | 2015 |
1 other study(ies) available for moxifloxacin and Brugada Syndrome
Article | Year |
---|---|
ECG evaluation of ventricular properties: the importance of cardiac cycle length.
Topics: Aza Compounds; Brugada Syndrome; Electrocardiography, Ambulatory; Fluoroquinolones; Heart Rate; Humans; Moxifloxacin; Quinolines; Signal Processing, Computer-Assisted; Ventricular Function | 2009 |